Adjuvant transarterial chemotherapy for margin-positive resection of hepatocellular carcinoma-a propensity score matched analysis.

Alvina Jada FokWong-Hoi SheKa Wing MaSimon H Y TsangWing Chiu DaiAlbert C Y ChanChung Mau LoTan To Cheung

Published in: Langenbeck's archives of surgery (2021)

Margin involvement is an adverse factor for survival in HCC. Adjuvant transarterial chemotherapy may offer survival benefits to hepatocellular carcinoma patients with positive surgical margins.

Keyphrases

early stage
locally advanced
radiofrequency ablation
liver metastases
radiation therapy
rectal cancer
adverse drug
electronic health record